Zanamivir overdosage

Jump to navigation Jump to search
Zanamivir
RELENZA® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
Directions for Use
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Overdosage

There have been no reports of overdosage from administration of RELENZA.[1]

References

  1. "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021036s019lbl.pdf" (PDF). External link in |title= (help)

Adapted from the FDA Package Insert.